19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace





powered by centersite dot net
Alzheimers Disease and other Cognitive Disorders
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Brain's Iron Stores May Be Key to Alzheimer'sHormones May Explain Greater Prevalence of Alzheimer's in WomenMiddle-Age Obesity Linked to Higher Odds for DementiaCould Crohn's, Colitis Raise Dementia Risk?5 Healthy Steps to Lower Your Odds for Alzheimer'sCOVID-19 Brings New Challenges to Alzheimer's CaregivingAlzheimer's Gene Linked to Severe COVID-19 RiskHealthier Heart, Better Brain in Old AgeAHA News: Hearing Loss and the Connection to Alzheimer's Disease, DementiaBrain Plaques Signal Alzheimer's Even Before Other Symptoms Emerge: StudyCertain Gene Might Help Shield At-Risk People From Alzheimer'sHow to Connect With Nursing Home Patients in QuarantineHow to Ease Loved Ones With Alzheimer's Through the PandemicCaring for Dementia Patient During Pandemic? Try These Stress-Busting TipsDirty Air Might Raise Your Odds for DementiaRecovery From Mild Brain Trauma Takes Longer Than Expected: StudyCould Sleep Apnea Put You at Risk for Alzheimer's?Daily Aspirin Won't Stop Dementia, Study FindsStudy Ties Brain Inflammation to Several Types of DementiaHeart Drug Combos Might Also Lower Your Dementia Risk: StudyU.S. Primary Care Docs Unprepared for Surge in Alzheimer's CasesMaria Shriver Sounds the Alarm on Women and Alzheimer'sTraumatic Brain Injuries Raise Risk of Psychiatric Ills in SoldiersGrowing Up in U.S. 'Stroke Belt' Bad for the Brain Later in LifeTwo Experimental Drugs Disappoint With Inherited Alzheimer'sGene Variant Ups Dementia Risk in Parkinson's Patients: StudyGene Variation May Protect Against Alzheimer's: StudyWhen Dementia Harms Speech, Native Language MattersEven 1 Night's Bad Sleep Can Raise Levels of a Brain 'Marker' for Alzheimer'sAHA News: Worried About Dementia? Check This Blood Pressure NumberStudy Might Point Alzheimer's Research in Whole New DirectionMore Doubt That Plaques in the Brain Cause Alzheimer'sObesity in Middle Age Could Raise Odds for Alzheimer's LaterCan Air Pollution Take a Toll on Your Memory?Animal Study Offers Hope for Treating Traumatic Brain InjuriesAlmost Half of Older Americans Fear Dementia, Try Untested Ways to Fight ItPeople Who Can't Read Face 2-3 Times Higher Dementia RiskEducation a Buffer Against Alzheimer's Among Blacks: StudyDown Syndrome Carries Raised Risk of Dementia by 55A Gene Kept One Woman From Developing Alzheimer's -- Could It Help Others?Number of Americans With Dementia Will Double by 2040: ReportIs Head Injury Causing Dementia? MRI Might ShowBanned Trans Fats Linked to Higher Dementia Risk: StudyFamily Can Help Keep Delirium at Bay After SurgeryPro Soccer Players More Likely to Develop Dementia: StudyDrug Limits Damage of Brain InjuryYour Personality as a Teen May Predict Your Risk of DementiaWhat Helps Calm Agitated Dementia Patients?AHA News: Growing – and Aging – Hispanic Population at Risk for DementiaAHA News: Yo-Yoing Blood Pressure Could Be Bad for Those With Alzheimer's
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

A New and Better Way to 'Stage' Alzheimer's Patients?

HealthDay News
by By Steven Reinberg
HealthDay Reporter
Updated: Jul 17th 2019

new article illustration

WEDNESDAY, July 17, 2019 (HealthDay News) -- One of the hallmarks of Alzheimer's is the accumulation of beta-amyloid plaques in the brain, but what part those plaques play in the development of the disease isn't clear.

Now researchers have taken the first steps to trace the progression of plaque buildup in living patients. This way of "staging" the disease has implications for research and one day may help doctors treat this debilitating, fatal disease.

"It is possible to stage individuals in terms of how advanced their beta-amyloid deposition is, using PET scans," said lead researcher Dr. Niklas Mattsson, an associate professor of clinical neuroscience at Lund University in Sweden.

When beta-amyloid appears, it follows certain stages, he explained. Some brain regions are involved early, others at the intermediate stage, and some in the late stage of Alzheimer's.

"These stages are also associated with other hallmarks of Alzheimer's disease, such as levels of tau [another type of protein] in cerebral spinal fluid, cognitive decline and the wasting away of brain cells," Mattsson added.

"This staging system can be used both to improve research and perhaps also in clinical trials, to see if certain drugs are likely to be most effective in certain stages of Alzheimer's," Mattsson said.

By the time Alzheimer's is typically diagnosed, the brain is already destroyed, said Meredith Braskie, an assistant professor of neurology at the University of Southern California in Los Angeles. She was not involved with the study.

The disease takes years to develop, which is why finding a way to diagnose it early is important, Braskie said. Most studies on plaque have been done on the brains of dead people.

"This study is important because they were looking at how amyloid spreads in living patients and coming up with stages for that," Braskie said.

Although no cure exists for Alzheimer's today, this finding could also help in testing drugs as they are developed, she said.

But, "this isn't directly related to patient care," Braskie said. "It's more for research to see if treatments are working."

For the study, Mattsson and his colleagues used PET scans from the Alzheimer's Disease Neuroimaging Initiative database. Among the 741 participants, 304 had no cognitive impairment, 384 had mild cognitive impairment, and 53 had Alzheimer's disease. Patients were followed up at two, four and six years.

At the start of the study, about 98% of the 2,072 scans weren't staged. Of those in the earliest stage of plaque development, about 15% would likely progress to a more advanced stage, as would 71% of those at stage 1 and 53% of those at stage 2.

As patients moved from stage 1 to stages 2 and 3, amyloid plaque developed in more vital areas of the brain, the researchers noted.

Interestingly, nearly 1% of the patients reverted to a lower stage, the researchers found. Higher stages were linked to higher concentrations of tau in cerebral spinal fluid. More tau in stage 2 indicated a more rapid progression to cognitive decline. The researchers were able to confirm their findings in a different group of 474 patients.

The areas affected in the brain differed in each stage and were also linked to differences in genetics, blood circulation, brain cell behavior and cholesterol levels.

"I think that it is clear from these data that the earlier the diagnosis of Alzheimer's is supported by amyloid imaging, the earlier clinicians are likely to initiate drug therapy," said Dr. Sam Gandy. He's chair of Alzheimer's Disease Research and director of the Mount Sinai Center for Cognitive Health and NFL Neurological Care in New York City.

This would be a change from current practice, which is not to start drug therapy until patients have advanced beyond the mild cognitive impairment and are well into mild Alzheimer's disease, said Gandy, who had no part in the study.

However, Gandy isn't sure that beginning drug therapy when mild cognitive impairment starts and a scan shows plaque would benefit all or only some patients.

Also, he would like to see if the staging system would work the same way among patients with and without the APOE gene mutations, which are linked to Alzheimer's.

"These data would potentially have some impact on care and on designing future research studies," Gandy said. "Whether those changes in practice would have meaningful benefits for patients is not clear."

The report was published online July 17 in the journal JAMA Neurology, to coincide with a presentation of the findings at the Alzheimer's Association annual meeting, in Los Angeles.

More information

For more on Alzheimer's disease, head to the Alzheimer's Association.